HomeAI · summaries
Storia in 2 fonti
Merck to create separate cancer business as Keytruda patent loss looms
Merck said on Monday it will split its human-health business into two divisions, separating its cancer franchise from its non-oncology medicines.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
cnbc.com
Merck to create separate cancer business as Keytruda patent loss looms
Merck said on Monday it will split its human-health business into two divisions, separating its cancer franchise from its non-oncology medicines.
- ·
ft.com
Merck splits operations to separate oncology from non-cancer drugs
Reshuffle in preparation for 2028 US patent expiry of blockbuster cancer treatment Keytruda